|
|
||||||||
MUCOSAL BIOLOGY
Veterans Affairs Medical Center, Long Beach, 90822; and University of California College of Medicine, Irvine, California 92697
Submitted 26 May 2004 ; accepted in final form 16 June 2004
Transcriptional regulation of expression of the human thiamin transporter-2 (the product of the SLC19A3 gene) is unknown. In this study, we cloned the 5'-regulatory region of the human SLC19A3 gene (2,016 bp), identified the minimal promoter region required for basal activity, demonstrated a critical role for specific cis-regulatory elements in determining the promoter activity, and confirmed activity and physiological relevance of the cloned SLC19A3 promoter in vivo. With the use of transiently transfected human intestinal epithelial Caco-2 cells and 5'-deletion analysis, the minimal promoter region required for basal activity of the SLC19A3 promoter was found to be encoded in a sequence between 77 and +59 by using the start of transcription initiation as position 1. This minimal region was found to contain a number of putative cis-regulatory elements, with a critical role for a stimulating protein-1 (SP1)/GC-box binding site (at position 48/45 bp) established by means of mutational analysis. With the use of EMSA and supershift assays, the binding of SP1 and SP3 to the minimal promoter region was also demonstrated. In transiently transfected Drosophila SL2 cells, both SP1 and SP3 transactivated the SLC19A3 minimal promoter in a dose-dependent manner and in combination demonstrated an additive stimulatory effect. Functionality of the full-length SLC19A3 promoter was confirmed in vivo in transgenic mice expressing the promoter-luciferase reporter gene. These studies report the first characterization of the SLC19A3 promoter in vitro and in vivo and demonstrate the importance of an SP1 cis-regulatory element in regulating promoter activity of this important human gene.
SLC19A3; thiamin transporter; transcriptional regulation
This article has been cited by other articles:
![]() |
B. Ashokkumar, N. D. Vaziri, and H. M. Said Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms Am J Physiol Renal Physiol, October 1, 2006; 291(4): F796 - F805. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lonsdale A Review of the Biochemistry, Metabolism and Clinical Benefits of Thiamin(e) and Its Derivatives. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 49 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shimakura, T. Terada, T. Katsura, and K.-I. Inui Characterization of the human peptide transporter PEPT1 promoter: Sp1 functions as a basal transcriptional regulator of human PEPT1 Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G471 - G477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Reidling and H. M. Said Adaptive regulation of intestinal thiamin uptake: molecular mechanism using wild-type and transgenic mice carrying hTHTR-1 and -2 promoters Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1127 - G1134. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |